Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
Stopped Study terminated due to reproducibility issues with genomics prediction model.
Conditions
- Non Small Cell Lung Cancer
Interventions
- DRUG: Cisplatin & Gemcitabine
- DRUG: Cisplatin & Pemetrexed
- DRUG: Docetaxel & Gemcitabine
- DRUG: Pemetrexed & Gemcitabine
Sponsor
Duke University
Collaborators